COX-2 Inhibition Versus Gastroprotection with Dual COX Inhibitors: An Evidence-Based Approach

E-ISSN： 1873-4286|9|27|2221-2228

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.27, 2003-10, pp. : 2221-2228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural Approach for COX-2 Inhibition

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-08 ,pp. : 603-615

Bentham Science Publishers

Access to resources Recommend Favorite

Dual COX-Inhibitors: The Answer is NO?

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-06 ,pp. : 487-492

Bentham Science Publishers

Access to resources Recommend Favorite

COX-1/COX-2 inhibitors based on the methanone moiety

By Dannhardt G. Fiebich B.L. Schweppenhauser J.

European Journal of Medicinal Chemistry, Vol. 37, Iss. 2, 2002-02 ,pp. : 147-161

Elsevier

Access to resources Recommend Favorite

Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 931-937

Bentham Science Publishers

Access to resources Recommend Favorite

COX-2 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1465-1468

Informa Healthcare

Access to resources Recommend Favorite